News by subject: Share Issue

Mogo Inc. ("Mogo" or the "Company"), one of Canada's leading financial technology companies, today announced that it has filed a preliminary short form base shelf prospectus (the "Shelf Prospectus") with the securities commissions in each of the...

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of restricted stock unit (RSU) awards for an aggregate of 16,050...

Viridian Therapeutics, Inc. (the "Company" or "Viridian"), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a majority of the independent...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has...

Eagle Point Income Company Inc. (the "Company") today announced, in connection with its previously disclosed underwritten public offering of 1,130,500 shares of its 7.75% Series B Term Preferred Stock due 2028 (the "Preferred Stock") at a public...

Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") , a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that it has commenced...

Astria Therapeutics, Inc. , a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, granted stock options to purchase...

Mednow Inc. ("Mednow" or the "Company"), Canada's on-demand virtual pharmacy, is pleased to announce the closing of the previously announced non-brokered private placement offering of a secured convertible debenture (the "Convertible Debenture")...

CenterPoint Energy, Inc. today announced the commencement of its offering of $900 million of Convertible Senior Notes due 2026 (the "convertible notes") in a private placement to persons reasonably believed to be qualified institutional buyers...

NOTIFICATION OF TOTAL VOTING RIGHTS AND CAPITAL IN THE COMPANY In accordance with DTR 5.6.1, the Company hereby notifies the following: The Company's issued share capital as at July 31, 2023 consisted of 232,171,182 ordinary shares of 10 pence...

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on July 31, 2023 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta's 2014 Employment...

Waste Management, Inc. ("WM" or the "Company") today announced that it has priced a public offering of $2,000,000,000 aggregate principal amount of senior notes under an effective shelf registration statement previously filed with the Securities and...

Carvana Co. ("Carvana" or the "Company"), the fastest growing used car dealer in U.S. history, today announced that it has raised $225 million through the issuance of approximately 4.9 million shares through its at-the-market equity offering program...

UroGen Pharma Ltd. (UroGen), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has entered into a definitive securities purchase agreement in...

Compute Health Acquisition Corp. ("Compute Health") today announced that at a special meeting of Compute Health's warrant holders held today (the "Warrant Holder Meeting"), the previously announced proposal to amend the warrant agreement that...

Naspers  (JSE:NPN) shareholders (Shareholders) are advised that notice is hereby given, in terms of the notice of annual general meeting posted to Shareholders today, on Wednesday, 26 July 2023 (Notice of Annual General Meeting), that the virtual...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company's Board of...

Netcapital Inc. ("Netcapital" or the "Company"), a digital private capital markets ecosystem, today announced the closing of its previously announced public offering of 1,725,000 shares of its common stock at a public offering price of $0.70 per...

VBI Vaccines Inc. (VBI or the Company), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the underwriters of its recent underwritten public offering of common...

DA32 Life Science Tech Acquisition Corp. today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock (the "Public Shares"), effective as of July 28, 2023, because the...

Frontier Communications Parent, Inc. ("Frontier" or the "Company") today announced that a limited-purpose, bankruptcy remote, indirect subsidiary of the Company intends to offer approximately $1.05 billion aggregate principal amount of secured fiber...

Coty Inc. ("Coty"), one of the world's largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, today announced that it, together with its wholly-owned subsidiaries, HFC Prestige Products,...

Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it priced an underwritten registered public offering of 3,380,282 shares of its common stock at a price of $17.75 per share for aggregate gross proceeds of $60 million. The...

Harrow , a leading U.S. eyecare pharmaceutical company, today announced a proposed underwritten registered public offering of its common stock, subject to market and certain other conditions. Harrow expects to grant the underwriters a 30-day option...

Bicycle Therapeutics plc , a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the closing on Monday, July 17, 2023 of its underwritten...

CEL-SCI Corporation ("CEL-SCI" or the "Company") , a Phase 3 cancer immunotherapy company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. The Company expects to grant the underwriter a...

Tivic Health® Systems, Inc. ("Tivic", "Company", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its previously announced public offering of 51,250,000 shares of its common...

Ault Alliance, Inc. , a diversified holding company, ("Ault Alliance" or the "Company"), hereby announces an update on its distribution (the "Second Distribution") related to securities of Imperalis Holding Corp. , d/b/a TurnOnGreen, Inc....

Bicycle Therapeutics plc , a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the pricing of an underwritten public offering of 9,411,766...

Bicycle Therapeutics plc , a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has commenced an underwritten public offering of...

1. PROSUS CIRCULAR AND ANNUAL GENERAL MEETING Naspers Limited ("Naspers") (JSE: NPN): Naspers shareholders (Shareholders) are referred to the joint announcement published by Naspers and Prosus N.V. (Prosus) on 27 June 2023 (the Transaction...

Mirum Pharmaceuticals, Inc. today announced that on July 10, 2023, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 44,850 shares of common stock and 22,430...

Fisker Inc. ("Fisker"), driven by a mission to create the world's most emotional and sustainable electric vehicles, today announced the signing of a securities purchase agreement in connection with its intention to offer (the "Offering")...

Kezar Life Sciences, Inc., , a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company's Board of Directors...

Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of a restricted stock unit (RSU) award for 9,000 shares of Syros...

VBI Vaccines Inc. ("VBI" or the "Company"), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has commenced an underwritten public offering and a registered...

Senseonics Holdings, Inc. , a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it had made equity grants to...

Transphorm, Inc. ("Transphorm" or the "Company") announced today that it has commenced its previously-announced rights offering. If the rights offering is fully subscribed, the Company will receive gross proceeds of $15 million, less expenses...

NOTIFICATION OF TOTAL VOTING RIGHTS AND CAPITAL IN THE COMPANY In accordance with DTR 5.6.1, the Company hereby notifies the following: The Company's issued share capital as at June 30, 2023 consisted of 232,171,182 ordinary shares of 10 pence...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on June 30, 2023. Seven individuals were hired by Adicet in June...

NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity inducement awards to 23 new employees. In accordance with Nasdaq...

Zivo Bioscience, Inc. , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that it has entered into a securities purchase...

Regulatory News: POXEL SA (Euronext: POXEL ? FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

Nextracker Inc. ("Nextracker") announced today that in connection with its previously announced underwritten offering of 14,210,511 shares of its Class A common stock ("Common Stock") offered by Nextracker and 2,289,489 shares of Common Stock...

Ironwood Pharmaceuticals, Inc. ("Ironwood") , a GI-focused healthcare company, and VectivBio Holding AG ("VectivBio") , a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal...

Trinity Industries, Inc. ("Trinity" or the "Company") today announced that it has finalized the terms of its offering (the "Offering") of $400.0 million aggregate principal amount of 7.750% Senior Notes due 2028 (the "Notes"). Trinity anticipates...

Jefferies Financial Group Inc. ("Jefferies") is pleased to announce that its shareholders overwhelmingly approved its Amended and Restated Certificate of Incorporation, which authorizes a new class of non-voting common stock, $1.00 par value per...

AST SpaceMobile, Inc. (the "Company" or "AST SpaceMobile") announced today the pricing and upsizing of its previously announced public offering of its Class A common stock, par value $0.0001 per share (the "Class A Common Stock"), in an underwritten...